Exodus sets fall 2024 North American headline tour

Veteran thrash metal act Exodus will hit road this fall on a North American tour dubbed The Battle of ’24. The band’s first headline run in many years will feature support from Havok, Candy and Dead Heat.

“Exodus are super stoked to announce ‘The Battle of ’24’, our tour with Havok, Candy and Dead Heat. This tour will be raging, and this is our first headlining tour in many years, so we’re excited to dig out some deep cuts, as well as play some more songs off of ‘Persona Non Grata,'” guitarist Gary Holt said. “Let the battle begin!”

The announcement follows Exodux’s recent signing to Napalm Records. Its latest album, “Persona Non Grata” (2021), debuted at number 1 on the Current Hard Music Albums chart and number 9 on the Billboard 200 with Hard Rock Genre chart in the Unite States.

Tour dates:

11/02/24: Tampa, FL @ The Orpheum
11/04/24: Orlando, FL @ House of Blues
11/05/24: Pensacola, FL @ Vinyl Music Hall
11/06/24: Atlanta, GA @ Heaven @ Masquerade
11/08/24: Dallas, TX @ Granada
11/09/24: Austin, TX @ Empire
11/11/24: Denver, CO @ Ogden
11/13/24: Des Moines, IA @ Wooly’s
11/14/24: Joliet, IL @ The Forge
11/15/24: Columbus, OH @ King of Clubs
11/16/24: Baltimore, MD @ Soundstage
11/17/24: Bethlehem, PA @ Wind Creek Event Center
11/18/24: Montreal, QC @ Beanfield Theatre
11/19/24: Toronto, ON @ Phoenix Concert Theatre
11/21/24: Worcester, MA @ Palladium Upstairs
11/22/24: Brooklyn, NY @ Warsaw
11/23/24: Pittsburgh, PA @ Preserving
11/24/24: Detroit, MI @ Majestic Theatre
11/26/24: Minneapolis, MN @ Varsity Theater
11/27/24: Winnipeg, MB @ Exchange Event Centre
11/29/24: Calgary, AB @ Palace Theatre
11/30/24: Edmonton, AB @ Union Hall
12/2/24 – Vancouver, BC – Rickshaw Theatre
12/3/24 – Seattle, WA – El Corazon
12/4/24 – Portland, OR – Hawthorne
12/6/24 – Berkeley, CA – UC Theatre
12/7/24 – Los Angeles, CA – The Regent

Leave a Reply

Powered by WordPress.com.

Up ↑

Discover more from Live Metal

Subscribe now to keep reading and get access to the full archive.

Continue reading